The novel approach of the medication represents a major advance in the handling of the condition. Unlike existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone – resulting in https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment